Cherokee Nation invests $16M to improve access to cancer care
TAHLEQUAH, Okla. – Cherokee Nation is investing $16 million in two area hospitals earmarked to provide critical cancer care closer to home for Cherokee Nation citizens and others in the region.
Cherokee Nation operates the largest tribal health care system in the country, with more than 2 million patient visits annually.
American Indian and Alaska Native populations in Oklahoma experience a 36% higher cancer incidence rate and a 73% higher cancer mortality rate compared to the general U.S. population. Limited access to diagnostic services and treatments has historically been a significant challenge for many patients. By partnering with leading healthcare institutions, the Cherokee Nation is taking meaningful steps to tackle these disparities head-on, according to Cherokee Nation data.
'Cherokee Nation Health Services diagnoses nearly 400 new cancer cases per year, and we know that having treatment facilities within 60 miles of our citizens significantly increases their chances of survival,' said Cherokee Nation Principal Chief Chuck Hoskin Jr. 'This investment ensures more hope and opportunity for our tribal citizens who need cancer care.'
'These facilities represent more than health care infrastructure – they are a beacon of hope for our families and communities who have long struggled with the devastating effects of cancer,' said Cherokee Nation Health Services CEO and Executive Director Dr. R. Stephen Jones. 'We are proud to lead in advancing health care equity.'
Cherokee Nation's $8 million investment in OU Health Stephenson Cancer Center will support the development of its new facility in Tulsa. This expansion will extend the advanced, research-driven care provided at the National Cancer Institute-designated center to residents of northeastern Oklahoma, where cancer mortality rates are among the highest in the state.
Patients at the new center will have access to hundreds of clinical trials and innovative cancer treatments, which will significantly improve their outcomes.
'We are grateful for the Cherokee Nation's generosity and for their partnership as we bring the highest level of cancer care and clinical trials to the people of northeastern Oklahoma. The Cherokee Nation shares our mission of ensuring that no Oklahoman has to compromise on the care they receive because of their geography. This gift represents a milestone in that effort.'
Gary Raskob, Ph.D., OU Health Sciences Senior Vice-President and Provost.
Since its opening, OU Health Stephenson Cancer Center has collaborated with the Cherokee Nation on initiatives such as lung cancer screenings, which provide early detection for high-risk patients. This new partnership will expand on those existing efforts and help address cancer disparities within tribal communities.
Mercy Fort Smith Oncology facilitates more than 25,000 patient visits annually. More than 5,000 residents in the hospital's service area are newly diagnosed with cancer each year.
Mercy's expansion of cancer services in Fort Smith will provide high-quality care to thousands of Cherokee Nation citizens in Northwest Arkansas and the River Valley. The tribe's $8 million contribution will support Mercy's capital campaign to create expanded patient access to screenings, diagnosis, treatment, and recovery. The hospital will more than double the number of oncology and radiation oncology providers, add surgical oncology specialists, incorporate essential technology, and expand patient access.
'Mercy's vision is to keep patients close to home while receiving care, which aligns with the Cherokee Nation's focus and continued investment in the health and well-being of its citizens. Fort Smith and the surrounding communities will benefit for years to come from this collaboration between Mercy and the Cherokee Nation, which will help address the needs of cancer patients by expanding access and enhancing the care that's currently available. We look forward to working together on a common goal: to improve the overall health and quality of care for local residents.'
Ryan Gehrig, Mercy Arkansas Communities president
'These new facilities will be a lifeline for families who want to stay close to their communities while receiving care,' said Cherokee Nation Deputy Chief Bryan Warner.
He said more treatment options on or near our reservation would benefit Cherokee citizens and the surrounding rural communities.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 hours ago
- Yahoo
Appendix cancers on the rise in younger generations, study finds
Although they are very rare, cancers of the appendix are on the rise, a new study finds. An analysis of a National Cancer Institute database found that compared with older generations, rates of appendix cancer have tripled among Gen X and quadrupled among millennials, according to the report, published Monday in the Annals of Internal Medicine. 'There is a disproportionate burden of appendix cancer among young individuals,' said the study's lead author, Andreana Holowatyj, an assistant professor of hematology and oncology at the Vanderbilt University Medical Center and Vanderbilt Ingram Cancer Center. Holowatyj's earlier research was 'the first to show that 1 in every 3 appendix cancers is diagnosed among adults younger than age 50,' she said in a phone interview. 'That's compared to 1 in every 8 colorectal cancers diagnosed among adults younger than age 50.' Still, appendix cancers are extremely rare: According to the National Cancer Institute, they occur at a rate of 1 to 2 per million people in the United States a year. To see whether rates of the cancer had changed over time, Holowatyj turned to the Surveillance, Epidemiology and End Results program, which includes data from nationally representative cancer registries that cover about 45.9% of the U.S. population. Overall, there were 4,858 cases of appendix cancer from 1975 through 2019. When the large proportion of patients diagnosed between ages 18 and 49 is combined with the new finding of a generational rise in Gen X and millennials, it's 'important that we find the causes underpinning these statistics in order to reverse this trend and reduce the disease burden,' Holowatyj said. The new study further confirms that there is a trend toward younger and younger patients from recent generations being hit with gastrointestinal cancers, said Dr. Andrea Cercek, a medical oncologist and a co-director of the Center for Early Onset Colorectal and GI Cancers at Memorial Sloan Kettering Cancer Center in New York City. In particular, rates of colorectal cancer in younger adults have been rising for several decades. The cause for the rise in such GI cancers needs more research. 'It's likely that there are environmental causes, which include exposures to food, water and micro plastics or lifestyle or dietary changes,' said Cercek, who wasn't involved with the new research. 'You can't really pin it down to one thing or another. It's likely multiple factors causing this rise after 1945.' The appendix is a small pouch that hangs off the large intestine on the lower right side of the abdomen. A blockage can lead to infection and inflammation, called appendicitis, which needs emergency treatment. Unlike other cancers of the GI tract, appendix cancers aren't easily found because they're not as easy to see on abdominal scans and won't be picked up by colonoscopies, said Dr. Deborah Doroshow, an associate professor of medicine at the Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai in New York City. 'So it's not easy to detect or screen for them.' In fact, Holowatyj said, about 95% of appendix cancers aren't spotted until after a person has appendicitis and the appendix is removed and examined by pathologists. As a result, the cancers tend to be at a late stage with poorer long-term prognoses, she added. Doroshow, who wasn't involved with the new study, said it's important for patients and their doctors to be more aware of subtle symptoms. Symptoms such as changes in energy level, a new persistent pain or unexplained weight loss in a young person shouldn't be ignored, she said. 'If a person is feeling that something is not right it's always best to get an opinion,' Doroshow said. 'We've diagnosed young people with cancer whom other health care providers had not taken seriously because they were young.' Women and people of color may find they need to advocate for themselves, she added. Doroshow said people shouldn't be worrying about every single abdominal pain. Rather, it's persistent pain that would be a concern. This article was originally published on
New York Post
17 hours ago
- New York Post
Appendix cancer has quadrupled in older millennials in the US
Researchers are reporting a startling spike in appendiceal adenocarcinoma (AA) — otherwise known as appendix cancer — in people born after 1945. Cases have more than tripled in Americans born between 1980 and 1985 and quadrupled in those born between 1985 and 1990, according to a new study out of Vanderbilt University Medical Center. 'I think it's alarming,' study author Andreana N. Holowatyj, an assistant professor of hematology and oncology, told The Post. Advertisement 3 A new study has identified an alarming spike in appendiceal adenocarcinoma (AA) — otherwise known as appendix cancer — in people born after 1945. top images – Appendix cancer is very rare, estimated to affect only about one or two people per 1 million per year, according to the National Cancer Institute. Indeed, Holowatyj's team identified only 4,858 people aged 20 and over who were diagnosed with AA between 1975 and 2019. Advertisement The findings, published Monday in the Annals of Internal Medicine, are nonetheless part of a troublesome trend. AA is yet another type of cancer that seems to be on the rise in younger adults — joining the ranks of colorectal, breast, uterine, kidney and pancreatic cancers. 'I think the fact that we're seeing birth cohort or generational effects across a plethora of cancer types is indeed alarming because it really stresses the need to understand what is underpinning this pattern in order for us to be able to actively reverse it,' Holowatyj said. 3 Experts point to lifestyle changes, such as more sedentary behavior, as a possible cause of the rise in cancer cases in younger people. StockPhotoPro – Advertisement As with other cancers, health experts aren't exactly sure what could be causing the jump in AA cases. 'I think it's going to be a constellation of factors that may be driving appendiceal cancer development,' Holowatyj said. 'One of the things we often think about is, what has changed across birth cohorts over time?' she said. Advertisement Holowatyj pointed to 'possibly the use of antibiotics, both in childhood and in the food chain, the industrialization of the food industry over time, the lifestyle patterns and the tripling of obesity since the 1970s, increasingly sedentary behavior, possibly environmental exposures that have changed across different parts of the country and over time.' Whatever the cause, she hopes this study encourages the public to be 'aware of this cancer, to know about the signs and symptoms of appendix cancers and know that we're seeing more cases diagnosed across generations.' 3 Most AA cases are diagnosed incidentally after someone has their appendix removed. Avocado_studio – Many of these symptoms can mimic appendicitis: Abdominal pain, often on the lower right side Bloating, diarrhea or constipation Feeling full after small meals Unexplained weight loss Nausea and vomiting Abdominal mass or swelling Holowatyj hopes that people with symptoms 'see a healthcare professional in a timely manner because it's truly critical to detect appendix cancer early.' There are no standardized screening tests for appendix cancers — most cases are diagnosed incidentally after someone has their appendix removed. 'I think it's important to understand that appendix cancer is actually diagnosed in younger ages more commonly than we see in other cancers,' she said, noting that one in three patients diagnosed with appendix cancer is under the age of 50, compared to one in eight for colon cancer.
Medscape
19 hours ago
- Medscape
Gen X, Millennials Face Higher Risk for Rare Appendix Cancer
The incidence of appendiceal adenocarcinoma in the United States more than tripled among those born in 1980 and rose more than fourfold among those born in 1985 compared with a cohort born in 1945, a study found. Greater recognition of appendix cancer as distinct from colon cancer could partly explain the results, but generational differences in exposures affecting cancer risk are also possible, the researchers said. METHODOLOGY: A retrospective cohort study analyzed 4858 cases of pathologically confirmed primary appendiceal adenocarcinoma diagnosed between 1975 and 2019 in patients aged 20 years or older from eight population-based cancer registries in the United States. Researchers used data from the National Cancer Institute's Surveillance, Epidemiology, and End Results Program to examine age-specific incidence rates across overlapping birth cohorts from 1891 to 1999. The analysis included four histologic subtypes: Mucinous (1840 cases), nonmucinous (1428 cases), goblet cell adenocarcinomas (1273 cases), and signet ring cell carcinomas (317 cases). Age-specific incidence rates were calculated per 100,000 persons in 5-year periods from 1975 to 2019, with the 1945 birth cohort serving as the reference group. TAKEAWAY: Compared with the 1945 reference cohort, the incidence rate ratio (IRR) for the 1980 birth cohort was 3.41 (95% CI, 2.54-4.56). For the 1985 cohort, the IRR was 4.62 (95% CI, 3.12-6.82). Goblet cell adenocarcinomas showed the most pronounced increase among histologic subtypes. IN PRACTICE: 'Birth cohort effects have also been reported for colon, rectal, and gastric cancer, suggesting that both shared and distinct risk factors may contribute to gastrointestinal carcinogenesis,' the researchers wrote. 'These results support the need for histology-specific investigations of appendiceal adenocarcinoma, as well as increased education and awareness of appendiceal adenocarcinomas among healthcare providers and the public.' SOURCE: Andreana N. Holowatyj, PhD, with Vanderbilt University School of Medicine, in Nashville, Tennessee, was the corresponding author of the study, which was published online on June 10 in Annals of Internal Medicine . LIMITATIONS: Appendix cancer had been treated as colon cancer until relatively recently, the researchers noted. But the increase in goblet cell carcinomas, which typically only occur in the appendix, 'suggests that misclassification of appendiceal versus colon cancer is unlikely to explain our findings,' Holowatyj's group wrote. DISCLOSURES: The study was supported by grants from the Appendix Cancer Pseudomyxoma Peritonei Research Foundation and the National Institutes of Health.
